Bernstein SocGen Reiterates Market Perform Rating for Merck
Bernstein SocGen Group analyst Courtney Breen has reiterated her Market Perform rating and $105.00 price target on Merck (NYSE: MRK).
The analyst made this announcement, but no specific reasoning was provided.
This is the latest in a series of updates from analysts regarding Merck's stock performance.